You searched for Emmarie Huetteman - Page 15 of 18 - California Healthline

GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices

By Emmarie Huetteman July 25, 2019

Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

By Emmarie Huetteman July 24, 2019

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers

By Emmarie Huetteman June 28, 2019

A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.

Universal Health Care For New Yorkers? Not Exactly

By Emmarie Huetteman June 27, 2019

Despite what New York Mayor Bill de Blasio claimed during the first night of the presidential debates, universal health care in the Big Apple is still in the seeding stage.

Trump Administration Rule Would Undo Health Care Protections For LGBTQ Patients

By Emmarie Huetteman June 13, 2019

Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

By Emmarie Huetteman June 12, 2019

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

March 1, 2019

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

Investors’ Deep-Pocket Push To Defend Surprise Medical Bills

By Rachel Bluth and Emmarie Huetteman September 11, 2019

As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.

Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High

By Emmarie Huetteman April 26, 2019

It’s as shady as it sounds.

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

By Emmarie Huetteman and Jay Hancock and Elizabeth Lucas August 27, 2019

Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.

Filter Results